Drug Allegedly Causes Stroke In Infant

Case Overview

This case involves the care of a neonate born at a hospital in Montana. The neonate needed to undergo a great vessel switch after birth in order to correct a genetic defect. During the surgery, the surgeons noticed unusual bleeding. The physicians administered Novo7 to assist in minimizing the surgical time. The drug immediately caused a stroke of the cerebral artery, rendering the child severely disabled.

Questions to the Pharmacy expert and their responses

According to the literature, is administering this drug to a neonate a safe and effective treatment option in excessive bleeding?

Depending on the nature of the genetic abnormality, the pharmacological effect of the Novo7 could be altered, or its dose could be incorrect for the patient’s metabolism, or the sensitivity to the Novo7 itself could be altered.

About the expert

This highly qualified Professor of Pharmaceutical Sciences received a bachelors in Pharmacy and a PharmD in Clinical Pharmacy. He is a member of numerous highly regarded professional organizations including the American Association of Pharmaceutical Scientists and the American College of Clinical Pharmacology. He is an innovator with 10 patents registered in his name. He is widely published in Pharmaceutical literature with over 350 articles. In addition to his academic role he currently serves as CEO of three Pharmaceutical companies.

E-008734

Specialties:

Pharmacy